181 related articles for article (PubMed ID: 31130245)
1. Risk Of Recurrence After Withdrawal Of Anticoagulation In Patients With Unprovoked Venous Thromboembolism: External Validation Of The Vienna Nomogram And The Dash Prediction Score.
Marín-Romero S; Elías-Hernández T; Asensio-Cruz MI; Ortega-Rivera R; Morillo-Guerrero R; Toral J; Montero E; Sánchez V; Arellano E; Sánchez-Díaz JM; Real-Domínguez M; Otero-Candelera R; Jara-Palomares L
Arch Bronconeumol (Engl Ed); 2019 Dec; 55(12):619-626. PubMed ID: 31130245
[TBL] [Abstract][Full Text] [Related]
2. External validation of the DASH prediction rule: a retrospective cohort study.
Tosetto A; Testa S; Martinelli I; Poli D; Cosmi B; Lodigiani C; Ageno W; De Stefano V; Falanga A; Nichele I; Paoletti O; Bucciarelli P; Antonucci E; Legnani C; Banfi E; Dentali F; Bartolomei F; Barcella L; Palareti G
J Thromb Haemost; 2017 Oct; 15(10):1963-1970. PubMed ID: 28762665
[TBL] [Abstract][Full Text] [Related]
3. Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH).
Tosetto A; Iorio A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Douketis J
J Thromb Haemost; 2012 Jun; 10(6):1019-25. PubMed ID: 22489957
[TBL] [Abstract][Full Text] [Related]
4. Predicting recurrence after unprovoked venous thromboembolism: prospective validation of the updated Vienna Prediction Model.
Tritschler T; Méan M; Limacher A; Rodondi N; Aujesky D
Blood; 2015 Oct; 126(16):1949-51. PubMed ID: 26341256
[TBL] [Abstract][Full Text] [Related]
5. D-dimer levels over time and the risk of recurrent venous thromboembolism: an update of the Vienna prediction model.
Eichinger S; Heinze G; Kyrle PA
J Am Heart Assoc; 2014 Jan; 3(1):e000467. PubMed ID: 24385451
[TBL] [Abstract][Full Text] [Related]
6. A risk score for prediction of recurrence in patients with unprovoked venous thromboembolism (DAMOVES).
Franco Moreno AI; García Navarro MJ; Ortiz Sánchez J; Martín Díaz RM; Madroñal Cerezo E; de Ancos Aracil CL; Cabello Clotet N; Perales Fraile I; Gimeno García S; Montero Hernández C; Zapatero Gaviria A; Ruiz Giardín JM
Eur J Intern Med; 2016 Apr; 29():59-64. PubMed ID: 26775136
[TBL] [Abstract][Full Text] [Related]
7. Risk of recurrence after a first unprovoked venous thromboembolism: external validation of the Vienna Prediction Model with pooled individual patient data.
Marcucci M; Iorio A; Douketis JD; Eichinger S; Tosetto A; Baglin T; Cushman M; Palareti G; Poli D; Tait RC; Kyrle PA
J Thromb Haemost; 2015 May; 13(5):775-81. PubMed ID: 25660555
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Venous Thromboembolism Recurrence Scores in an Unprovoked Pulmonary Embolism Population: A Post-hoc Analysis of the PADIS-PE trial.
Raj L; Presles E; Le Mao R; Robin P; Sanchez O; Pernod G; Bertoletti L; Jego P; Lemarié CA; Leven F; Hoffmann C; Planquette B; Le Roux PY; Slaun PY; Nonent M; Girard P; Lacut K; Mélac S; Guégan M; Mismetti P; Laporte S; Meyer G; Leroyer C; Tromeur C; Couturaud F;
Am J Med; 2020 Aug; 133(8):e406-e421. PubMed ID: 32333853
[TBL] [Abstract][Full Text] [Related]
9. Systematic review of prognostic models for recurrent venous thromboembolism (VTE) post-treatment of first unprovoked VTE.
Ensor J; Riley RD; Moore D; Snell KI; Bayliss S; Fitzmaurice D
BMJ Open; 2016 May; 6(5):e011190. PubMed ID: 27154483
[TBL] [Abstract][Full Text] [Related]
10. Association between anticoagulant treatment duration and risk of venous thromboembolism recurrence and bleeding in clinical practice.
Kaatz S; Fu AC; AbuDagga A; LaMori J; Bookhart BK; Damaraju CV; Tan H; Schein J; Nutescu E
Thromb Res; 2014 Oct; 134(4):807-13. PubMed ID: 25127013
[TBL] [Abstract][Full Text] [Related]
11. Risk of thrombosis recurrence among patients with COVID-19 and surgery-associated venous thromboembolism.
Alonso-Beato R; Lago-Rodríguez MO; López-Rubio M; Gómez-Tórtola A; García-Fernández-Bravo I; Oblitas CM; Galeano-Valle F; Demelo-Rodríguez P
Rev Clin Esp (Barc); 2023 May; 223(5):255-261. PubMed ID: 36990384
[TBL] [Abstract][Full Text] [Related]
12. The Vienna Prediction Model for identifying patients at low risk of recurrent venous thromboembolism: a prospective cohort study.
Kyrle PA; Eischer L; Šinkovec H; Gressenberger P; Gary T; Brodmann M; Heinze G; Eichinger S
Eur Heart J; 2024 Jan; 45(1):45-53. PubMed ID: 37769352
[TBL] [Abstract][Full Text] [Related]
13. Effect of tailoring anticoagulant treatment duration by applying a recurrence risk prediction model in patients with venous thromboembolism compared to usual care: A randomized controlled trial.
Geersing GJ; Hendriksen JMT; Zuithoff NPA; Roes KC; Oudega R; Takada T; Schutgens REG; Moons KGM
PLoS Med; 2020 Jun; 17(6):e1003142. PubMed ID: 32589630
[TBL] [Abstract][Full Text] [Related]
14. Low discriminating power of the modified Ottawa VTE risk score in a cohort of patients with cancer from the RIETE registry.
Alatri A; Mazzolai L; Font C; Tafur A; Valle R; Marchena PJ; Ballaz A; Tiraferri E; Font L; Monreal M; Riete Investigators T
Thromb Haemost; 2017 Jul; 117(8):1630-1636. PubMed ID: 28517021
[TBL] [Abstract][Full Text] [Related]
15. Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study.
Rokx C; Borjas Howard JF; Smit C; Wit FW; Pieterman ED; Reiss P; Cannegieter SC; Lijfering WM; Meijer K; Bierman W; Tichelaar V; Rijnders BJA;
PLoS Med; 2020 May; 17(5):e1003101. PubMed ID: 32407386
[TBL] [Abstract][Full Text] [Related]
16. D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study.
Kearon C; Spencer FA; O'Keeffe D; Parpia S; Schulman S; Baglin T; Stevens SM; Kaatz S; Bauer KA; Douketis JD; Lentz SR; Kessler CM; Moll S; Connors JM; Ginsberg JS; Spadafora L; Julian JA;
Ann Intern Med; 2015 Jan; 162(1):27-34. PubMed ID: 25560712
[TBL] [Abstract][Full Text] [Related]
17. Prediction of risk of recurrence of venous thromboembolism following treatment for a first unprovoked venous thromboembolism: systematic review, prognostic model and clinical decision rule, and economic evaluation.
Ensor J; Riley RD; Jowett S; Monahan M; Snell KIe; Bayliss S; Moore D; Fitzmaurice D;
Health Technol Assess; 2016 Feb; 20(12):i-xxxiii, 1-190. PubMed ID: 26879848
[TBL] [Abstract][Full Text] [Related]
18. Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis.
Khan F; Rahman A; Carrier M; Kearon C; Weitz JI; Schulman S; Couturaud F; Eichinger S; Kyrle PA; Becattini C; Agnelli G; Brighton TA; Lensing AWA; Prins MH; Sabri E; Hutton B; Pinede L; Cushman M; Palareti G; Wells GA; Prandoni P; Büller HR; Rodger MA;
BMJ; 2019 Jul; 366():l4363. PubMed ID: 31340984
[TBL] [Abstract][Full Text] [Related]
19. [Optimal duration of anticoagulation of venous thromboembolism].
Savina EN; Couturaud F
J Mal Vasc; 2011 Dec; 36 Suppl 1():S28-32. PubMed ID: 22177766
[TBL] [Abstract][Full Text] [Related]
20. Outcome after discontinuing anticoagulant therapy in women with venous thromboembolism during hormonal use.
Blanco-Molina Á; Trujillo-Santos J; Pesavento R; Rosa V; Falgá C; Tolosa C; Mazzolai L; Sampériz Á; Duce R; Monreal M;
Thromb Res; 2017 Mar; 151 Suppl 1():S6-S10. PubMed ID: 28262237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
